MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-02-28.

Income Overview

Net Income
-$44,098
Unit: Dollar

Income Statement
2026-02-28
2025-11-30
2025-08-31
2025-05-31
Services
0 0 0* 0
Cost of services
0 ---
Gross profit
0 ---
Research and development expense
0 -0* 0
General and administrative expenses
72,963 64,002 162,286.25* 40,380
Total operating expenses
72,963 64,002 162,286.25* 40,380
Loss from operations
-72,963 -64,002 -162,286.25* -40,380
Capital loss
0 ---
Financial income (loss), net
28,865 -49,717 --19,347
Capital loss
--0* -
Capital gain (loss)
---0
Financial loss, net
--10,571.25* -
Net (loss)
-44,098 -113,719 -172,857.5 -59,727
Profit (loss) from available for sale assets
0 0 -0
Total comprehensive income (loss)
-44,098 -113,719 -172,857.5 -59,727
Basic EPS
0 0 -0.001 0
Diluted EPS
0 0 -0.001 0
Basic Average Shares
931,015,714 732,857,211 198,239,676 42,597,394
Diluted Average Shares
931,015,714 732,857,211 198,239,676 42,597,394
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Total comprehensiveincome (loss)-$44,098 Net (loss)-$44,098 Financial income (loss),net$28,865 Loss from operations-$72,963 Total operatingexpenses$72,963 General andadministrative expenses$72,963

CNBX Pharmaceuticals Inc. (CNBX)

CNBX Pharmaceuticals Inc. (CNBX)